Boston Scientific to Buy Relievant Medsystems for Initial $800 Million

By Colin Kellaher


Boston Scientific has agreed to acquire smaller medical-technology company Relievant Medsystems for an initial $850 million in cash in a deal that expands its portfolio of...

Related Keywords

Boston ,Massachusetts ,United States ,Relievant Intracept ,Relievant Medsystems ,Colin Kellaher ,Boston Scientific ,Drug Administration ,Dow Jones ,Markets ,